Skip to content

Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.

Docket No. Op. Below Argument Opinion Vote Author Term
13-854 Fed. Cir. Oct 15, 2014 Jan 20, 2015 7-2 Breyer OT 2014

Holding: When reviewing a district court"s resolution of subsidiary factual matters made in the course of its construction of a patent claim, the Federal Circuit must apply a "clear error," not a de novo, standard of review.

Judgment: Reversed and remanded, 7-2, in an opinion by Justice Breyer on January 20, 2015. Justice Thomas filed a dissenting opinion, in which Justice Alito joined.

SCOTUSblog Coverage

DateProceedings and Orders (key to color coding)
11/04/2013Application (13A458) to recall and stay mandate pending the filing and disposition of a petition for a writ of certiorari, submitted to The Chief Justice.
11/05/2013Response to the application (13A458) requested by The Chief Justice, due Tuesday, November 12, 2013, by 10 a.m.
11/12/2013Response to application from respondent Sandoz, Inc., et al. filed.
11/13/2013Reply of applicant Teva Pharmaceuticals USA, Inc., et al. filed.
11/13/2013Application (13A458) denied by The Chief Justice.
01/16/2014Petition for a writ of certiorari filed. (Response due February 18, 2014)
02/05/2014Brief of respondents Sandoz, Inc., et al. in opposition filed.
02/19/2014DISTRIBUTED for Conference of March 7, 2014.
02/26/2014Reply of petitioners Teva Pharmaceuticals USA, Inc., et al. filed. (Distributed)
03/10/2014DISTRIBUTED for Conference of March 21, 2014.
03/24/2014DISTRIBUTED for Conference of March 28, 2014.
03/31/2014Petition GRANTED.
04/04/2014Application (13A1003) to recall and stay the mandate of the United States Court of Appeals for the Federal Circuit pending the sending down of the judgment of this Court, submitted to The Chief Justice.
04/08/2014Response to the application (13A1003) to recall and stay the mandate requested by The Chief Justice. The response is due Monday, April 14, 2014, by 5 p.m.
04/14/2014Response to application from respondents and motion for leave to file under seal declarations in support of respondents filed.
04/17/2014Reply of applicant Teva Pharmaceuticals USA, Inc., et al. filed.
04/18/2014Application (13A1003) denied by The Chief Justice. (In Chambers Opinion)
05/05/2014The time to file the joint appendix and petitioners' brief on the merits is extended to and including June 13, 2014.
05/05/2014The time to file respondents' brief on the merits is extended to and including August 11, 2014.
05/16/2014Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for respondents Mylan Pharmaceuticals, Inc., et al.
06/13/2014Joint appendix filed. (5 Volumes) (Statement of costs filed.)
06/13/2014Brief of petitioners Teva Pharmaceuticals USA, Inc., et al. filed.
06/13/2014Motion for leave to file Volume 4 of the joint appendix under seal filed by petitioners Teva Pharmaceuticals USA, Inc., et al.
06/16/2014Brief amicus curiae of the United States in support of neither party filed.
06/16/2014Brief amicus curiae of Federation Internationale Des Conseils En Propriete Intellectuelle (FICPI) in support of neither party filed.
06/18/2014Motion DISTRIBUTED for Conference of September 29, 2014.
06/20/2014Brief amici curiae of Professors Peter S. Menell, et al. in support of neither party filed.
06/20/2014Brief amicus curiae of Houston Intellectual Property Law Association in support of neither party filed.
06/20/2014Brief amicus curiae of American Bar Association in support of neither party filed.
06/20/2014Brief amicus curiae of Fresenius Kabi USA, LLC in support of neither party filed.
06/20/2014Brief amicus curiae of American Intellectual Property Law Association in support of neither party filed.
06/20/2014Brief amicus curiae of Intellectual Property Owners Association in support of neither party filed.
07/09/2014Record requested from U.S.C.A. Federal Circuit.
07/18/2014SET FOR ARGUMENT ON Wednesday, Octobert 15, 2014
07/21/2014Record received from U.S.D.C. Southern District of New York (3 Boxes), the records in this case are SEALED.
07/21/2014Record received from U.S.C.A. Federal Circuit. The record is located on PACER, confidential documents are filed electronically.
08/11/2014Brief of respondents Sandoz, Inc., et al. filed.
08/14/2014CIRCULATED.
08/16/2014Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument filed.
08/18/2014Brief amici curiae of Intel Corporation, et al. filed. (Distributed)
08/18/2014Brief amici curiae of Google Inc., et al. filed. (Distributed)
09/10/2014Reply of petitioners Teva Pharmaceuticals USA, Inc., et al. filed. (Distributed)
10/02/2014Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument GRANTED.
10/02/2014Motion for leave to file Volume 4 of the joint appendix under seal GRANTED.
10/15/2014Argued. For petitioners: William M. Jay, Washington, D. C. For United States, as amicus curiae: Ginger D. Anders, Assistant to the Solicitor General, Washington, D. C. For respondents: Carter G. Phillips, Washington, D. C.
01/20/2015Judgment VACATED and case REMANDED. Breyer, J., delivered the opinion of the Court, in which Roberts, C. J., and Scalia, Kennedy, Ginsburg, Sotomayor, and Kagan, JJ., joined. Thomas, J., filed a dissenting opinion, in which Alito, J., joined.
01/23/2015Application (14A792) for issuance of the mandate forthwith, submitted to Justice Breyer.
01/26/2015Application (14A792) denied without prejudice by Justice Breyer.
02/18/2015JUDGMENT ISSUED.
02/20/2015Record returned to U.S.D.C. Southern District of New York. 3 Boxes.